Jeffrey Settleman, Ph.D.: "Targeting Chromatin Modifiers to Overcome Resistance to Anti-cancer Drugs"

Jeffrey Settleman, Ph.D.:

Jeffrey Settleman, Ph.D.: "Targeting Chromatin Modifiers to Overcome Resistance to Anti-cancer Drugs"

Wednesday, October 23, 2013 - 4:00pm

Joseph N. Grossman, M.D. Auditorium
The Wistar Institute
3601 Spruce Street
Philadelphia, Pennsylvania 19104

Jeffrey Settleman, Ph.D., of Genentech, Inc., will be presenting this lecture.

Free and open to the public. For more information, call 215-898-3944.